indium (in-111) chloride curium 370 mbq/ml radiopharmac. precursor i.v. vial
curium belgium s.p.r.l.-b.v.b.a. - indium (111 in) chloride 370 mbq/ml - radiopharmaceutical precursor - 370 mbq/ml - indium (in-111) chloride 370 mbq/ml - indium (111in) compounds
ge healthcare sodium chromate (51cr) 37 mbq/ml radiopharmac. precursor i.v. vial
ge healthcare bv-srl - sodium chromate (51 cr) 37 mbq/ml - radiopharmaceutical precursor - chromium (51cr) chromate labelled cells
indium [in-111] chloride 111mbq/0.3ml radiopharmaceutical precursor solution vials
curium pharma uk ltd - indium [in-111] chloride - radiopharmaceutical precursor solution - 370mbq/1ml
indium [in-111] chloride 185mbq/0.5ml radiopharmaceutical precursor solution vials
curium pharma uk ltd - indium [in-111] chloride - radiopharmaceutical precursor solution - 370mbq/1ml
indium [in-111] chloride 370mbq/1ml radiopharmaceutical precursor solution vials
curium pharma uk ltd - indium [in-111] chloride - radiopharmaceutical precursor solution - 370mbq/1ml
indium [in-111] chloride 740mbq/2ml radiopharmaceutical precursor solution vials
curium pharma uk ltd - indium [in-111] chloride - radiopharmaceutical precursor solution - 370mbq/1ml
monlutenca 40 gbq/ml radiopharmac. precursor sol. i.v. vial
monrol europe s.r.l. - lutetium (lu-177) chloride 40 gbq/ml - radiopharmaceutical precursor, solution - other therapeutic radiopharmaceuticals
suprecur depot
sanofi-aventis ireland limited - buserelin acetate - pdr+solv for soln for inj - 3.6 milligram
suprecur nasal spray
sanofi-aventis new zealand limited - buserelin acetate 1.575 mg/g equivalent to 1.50 mg/ml buserelin - nasal spray solution - 150 mcg/dose - active: buserelin acetate 1.575 mg/g equivalent to 1.50 mg/ml buserelin excipient: benzalkonium chloride citric acid monohydrate sodium chloride sodium citrate dihydrate water for injection
suprecur solution for injection 1mg/ml
jv healthcare limited - buserelin - solution for injection - buserelin 1 milligram(s)/millilitre - endocrine therapy